Company / Capital Expenditures
KYNTRA BIO, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$266.0K
FY2025
5-year range
$266.0K / $5.8M
FY2021-FY2025
Trend
-89.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $266,000 in FY2025 to $9M in FY2019.
Based on SEC 10-K filings.
$266,000 in FY2025 with a 5-year CAGR of -49.4%.
Declined from $5M to $266,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -59.5%
- 5-Year CAGR
- -49.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -49.4%, indicating a declining trend.
- In FY2025, capital expenditures decreased 89.4% year-over-year.
- Peak capital expenditures was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $266.0K | -89.4% |
| FY2024 | $2.5M | -51.4% |
| FY2023 | $5.2M | +29.8% |
| FY2022 | $4.0M | -30.7% |
| FY2021 | $5.8M | -28.2% |
| FY2020 | $8.0M | -5.6% |
| FY2019 | $8.5M | +578.9% |
| FY2018 | $1.3M | -36.7% |
| FY2017 | $2.0M | -75.6% |
| FY2016 | $8.1M | +19.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026